Site icon AIT365

uMethod Health & Linus Health Streamline Brain Assessments

uMethod Health

uMethod Health, a pioneer in personalized cognitive care planning, has announced that it is collaborating with Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer’s and other dementias, to create a more efficient and effective approach to brain health. The collaboration provides clinicians with an integrated solution for earlier detection of cognitive impairment plus care planning.

With the increasing prevalence of cognitive impairment, including Alzheimer’s and other dementias, there is a critical need for innovative solutions that bridge the gap between assessment, diagnosis, and actionable care. The combined solution simplifies the complexities of clinical workflows, offering precise insights for healthcare providers to deliver more effective care across their patient populations.

Closing Care Gaps with Advanced Technologies

The collaboration between uMethod Health and Linus Health empowers clinicians with:

Also Read: Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2

Empowering Patients and Clinics

Both uMethod Health and Linus Health are committed to equipping clinicians and patients with the tools they need to navigate complex cognitive care with the integrated solution, which offers:

“By combining Linus Health’s advanced cognitive assessment capabilities with uMethod’s personalized care planning, we can help identify individuals in need earlier and significantly enhance the management of their cognitive disorders–ultimately improving patient outcomes,” said David Bates, PhD, Linus Health CEO and co-founder.

Vik Chandra, CEO of uMethod Health, said: “This partnership represents a significant step forward in cognitive care. Together, uMethod and Linus Health are simplifying the complexities of cognitive care workflows and providing clinicians with the tools they need for informed, precise decisions that benefit ALL their patients.”

Source: PRNewswire

Exit mobile version